181 related articles for article (PubMed ID: 35350534)
1. Novel Nongenetic Murine Model of Hyperglycemia and Hyperlipidemia-Associated Aggravated Atherosclerosis.
Gaul S; Shahzad K; Medert R; Gadi I; Mäder C; Schumacher D; Wirth A; Ambreen S; Fatima S; Boeckel JN; Khawaja H; Haas J; Brune M; Nawroth PP; Isermann B; Laufs U; Freichel M
Front Cardiovasc Med; 2022; 9():813215. PubMed ID: 35350534
[TBL] [Abstract][Full Text] [Related]
2. Induction of sustained hypercholesterolemia by single adeno-associated virus-mediated gene transfer of mutant hPCSK9.
Roche-Molina M; Sanz-Rosa D; Cruz FM; García-Prieto J; López S; Abia R; Muriana FJ; Fuster V; Ibáñez B; Bernal JA
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):50-9. PubMed ID: 25341796
[TBL] [Abstract][Full Text] [Related]
3. A novel mouse model of diabetes, atherosclerosis and fatty liver disease using an AAV8-PCSK9-D377Y injection and dietary manipulation in db/db mice.
Xu M; Wu X; Liu Z; Ding Y; Kong W; Little PJ; Xu S; Weng J
Biochem Biophys Res Commun; 2022 Sep; 622():163-169. PubMed ID: 35868060
[TBL] [Abstract][Full Text] [Related]
4. New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway.
Tang ZH; Peng J; Ren Z; Yang J; Li TT; Li TH; Wang Z; Wei DH; Liu LS; Zheng XL; Jiang ZS
Atherosclerosis; 2017 Jul; 262():113-122. PubMed ID: 28535426
[TBL] [Abstract][Full Text] [Related]
5. The AAV-PCSK9 murine model of atherosclerosis and metabolic dysfunction.
Keeter WC; Carter NM; Nadler JL; Galkina EV
Eur Heart J Open; 2022 May; 2(3):oeac028. PubMed ID: 35919346
[TBL] [Abstract][Full Text] [Related]
6. Absence of gravin-mediated signaling inhibits development of high-fat diet-induced hyperlipidemia and atherosclerosis.
Fan Q; Yin X; Rababa'h A; Diaz Diaz A; Wijaya CS; Singh S; Suryavanshi SV; Vo HH; Saeed M; Zhang Y; McConnell BK
Am J Physiol Heart Circ Physiol; 2019 Oct; 317(4):H793-H810. PubMed ID: 31441691
[TBL] [Abstract][Full Text] [Related]
7. A wild-type mouse-based model for the regression of inflammation in atherosclerosis.
Peled M; Nishi H; Weinstock A; Barrett TJ; Zhou F; Quezada A; Fisher EA
PLoS One; 2017; 12(3):e0173975. PubMed ID: 28291840
[TBL] [Abstract][Full Text] [Related]
8. The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice.
Landlinger C; Pouwer MG; Juno C; van der Hoorn JWA; Pieterman EJ; Jukema JW; Staffler G; Princen HMG; Galabova G
Eur Heart J; 2017 Aug; 38(32):2499-2507. PubMed ID: 28637178
[TBL] [Abstract][Full Text] [Related]
9. Exogenous Insulin Infusion Can Decrease Atherosclerosis in Diabetic Rodents by Improving Lipids, Inflammation, and Endothelial Function.
Park K; Li Q; Evcimen ND; Rask-Madsen C; Maeda Y; Maddaloni E; Yokomizo H; Shinjo T; St-Louis R; Fu J; Gordin D; Khamaisi M; Pober D; Keenan H; King GL
Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):92-101. PubMed ID: 29162603
[TBL] [Abstract][Full Text] [Related]
10. Effects of High Fat Feeding and Diabetes on Regression of Atherosclerosis Induced by Low-Density Lipoprotein Receptor Gene Therapy in LDL Receptor-Deficient Mice.
Willecke F; Yuan C; Oka K; Chan L; Hu Y; Barnhart S; Bornfeldt KE; Goldberg IJ; Fisher EA
PLoS One; 2015; 10(6):e0128996. PubMed ID: 26046657
[TBL] [Abstract][Full Text] [Related]
11. Hypercholesterolemia Induced by a PCSK9 Gain-of-Function Mutation Augments Angiotensin II-Induced Abdominal Aortic Aneurysms in C57BL/6 Mice-Brief Report.
Lu H; Howatt DA; Balakrishnan A; Graham MJ; Mullick AE; Daugherty A
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1753-7. PubMed ID: 27470509
[TBL] [Abstract][Full Text] [Related]
12. Absence of Nicotinamide Nucleotide Transhydrogenase in C57BL/6J Mice Exacerbates Experimental Atherosclerosis.
Vozenilek AE; Vetkoetter M; Green JM; Shen X; Traylor JG; Klein RL; Orr AW; Woolard MD; Krzywanski DM
J Vasc Res; 2018; 55(2):98-110. PubMed ID: 29455203
[TBL] [Abstract][Full Text] [Related]
13. Göttingen minipig model of diet-induced atherosclerosis: influence of mild streptozotocin-induced diabetes on lesion severity and markers of inflammation evaluated in obese, obese and diabetic, and lean control animals.
Ludvigsen TP; Kirk RK; Christoffersen BØ; Pedersen HD; Martinussen T; Kildegaard J; Heegaard PM; Lykkesfeldt J; Olsen LH
J Transl Med; 2015 Sep; 13():312. PubMed ID: 26394837
[TBL] [Abstract][Full Text] [Related]
14. Adeno-Associated Virus-Mediated Gain-of-Function mPCSK9 Expression in the Mouse Induces Hypercholesterolemia, Monocytosis, Neutrophilia, and a Hypercoagulative State.
Louloudis G; Ambrosini S; Paneni F; Camici GG; Benke D; Klohs J
Front Cardiovasc Med; 2021; 8():718741. PubMed ID: 34631822
[TBL] [Abstract][Full Text] [Related]
15. Gene inactivation of proprotein convertase subtilisin/kexin type 9 reduces atherosclerosis in mice.
Denis M; Marcinkiewicz J; Zaid A; Gauthier D; Poirier S; Lazure C; Seidah NG; Prat A
Circulation; 2012 Feb; 125(7):894-901. PubMed ID: 22261195
[TBL] [Abstract][Full Text] [Related]
16. SOAT1 deficiency attenuates atherosclerosis by regulating inflammation and cholesterol transportation via HO-1 pathway.
Wu N; Li RQ; Li L
Biochem Biophys Res Commun; 2018 Jun; 501(2):343-350. PubMed ID: 29567472
[TBL] [Abstract][Full Text] [Related]
17. E-cigarette exposure causes early pro-atherogenic changes in an inducible murine model of atherosclerosis.
Alakhtar B; Guilbert C; Subramaniam N; Caruana V; Makhani K; Baglole CJ; Mann KK
Front Toxicol; 2023; 5():1244596. PubMed ID: 38164438
[No Abstract] [Full Text] [Related]
18. No Significant Role for Smooth Muscle Cell Mineralocorticoid Receptors in Atherosclerosis in the Apolipoprotein-E Knockout Mouse Model.
Moss ME; DuPont JJ; Iyer SL; McGraw AP; Jaffe IZ
Front Cardiovasc Med; 2018; 5():81. PubMed ID: 30038907
[No Abstract] [Full Text] [Related]
19. Hyperlipidemia-induced apoptosis of hippocampal neurons in apoE(-/-) mice may be associated with increased PCSK9 expression.
Zhao XS; Wu Q; Peng J; Pan LH; Ren Z; Liu HT; Jiang ZS; Wang GX; Tang ZH; Liu LS
Mol Med Rep; 2017 Feb; 15(2):712-718. PubMed ID: 28000893
[TBL] [Abstract][Full Text] [Related]
20. TLR4 antagonist attenuates atherogenesis in LDL receptor-deficient mice with diet-induced type 2 diabetes.
Lu Z; Zhang X; Li Y; Lopes-Virella MF; Huang Y
Immunobiology; 2015 Nov; 220(11):1246-54. PubMed ID: 26162692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
